Governance RaQualia Pharma Inc.

4579

JP3967150008

Pharmaceuticals

Delayed Japan Exchange Other stock markets 12:00:00 17/06/2026 pm IST			5-day change	1st Jan Change
490.00 ^JPY	+3.38%		+3.81%	-51.49%

15/05	RaQualia Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
13/02	RaQualia Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Executive Committee: RaQualia Pharma Inc.

Manager

Positions heldSince

Manabu Sato

Comptroller/Controller/Auditor	-
Director of Finance/CFO	-
Investor Relations Contact	-

Kiyoshi Kawamura

Chief Tech/Sci/R&D Officer

Motonori Shimizu

Chief Administrative Officer

Composition of the Board of Directors: RaQualia Pharma Inc.

Director

CommitteesSince

Kosuke Ishii

43 year

Audit Committee	25/03/2021
Compensation Committee Chair	25/03/2021
Nominating Committee Chair	25/03/2021
Audit Committee Chair	01/11/2022

Takayuki Nakano

54 year

Audit Committee	01/03/2025
Compensation Committee	01/03/2025
Nominating Committee	01/03/2025

Yuichi Kakinuma

48 year

Audit Committee	25/03/2021
Compensation Committee	25/03/2021
Nominating Committee	25/03/2021

Geun-Seok Song

58 year

Director/Board Member

25/03/2026

Masaharu Tani

52 year

Director/Board Member	25/03/2026
Independent Dir/Board Member	25/03/2026

Atsushi Tanase

69 year

Director/Board Member	25/03/2026
Independent Dir/Board Member	25/03/2026

Katsuhiro Uto

52 year

Director/Board Member

01/03/2022

Masaki Sudo

54 year

Director/Board Member

01/03/2022

Former Officers and Directors: RaQualia Pharma Inc.

Insider

Positions held

SinceUntil

Michihiro Tsuchiya

Director/Board Member	26/03/2020	25/03/2026
Independent Dir/Board Member	26/03/2020	25/03/2026

Hirofumi Takeuchi

Comptroller/Controller/Auditor	01/01/2014	25/03/2021
Director/Board Member	25/03/2021	25/03/2025
Investor Relations Contact	-	-

Megumi Uzu

Director/Board Member

25/03/2021

25/03/2025

Shuzo Watanabe

Director/Board Member	01/03/2016	25/03/2022
Corporate Officer/Principal	01/10/2012	25/03/2021

Gakuji Nomoto

Director/Board Member	01/03/2016	-
Independent Dir/Board Member	01/03/2016	-

Shinnosuke Maki

Director/Board Member	01/03/2016	-
Independent Dir/Board Member	01/03/2016	-

Yasuhiro Takamatsu

Director/Board Member	26/03/2020	-
Human Resources Officer	01/01/2015	26/03/2020
General Counsel	01/02/2019	-

Taisuke Inagaki

Chief Operating Officer

14/07/2011

08/06/2012

Hiroki Narita

Director/Board Member

14/07/2011

31/10/2011

Hatsuo Aoki

Director/Board Member	01/03/2012	-
Independent Dir/Board Member	01/03/2012	-

Naoki Tani

Director/Board Member	01/10/2010	-
Founder	01/04/2010	-
Corporate Officer/Principal	01/04/2010	01/08/2012

Hisaji Agata

Director/Board Member	01/03/2016	-
Independent Dir/Board Member	01/03/2016	-

Kiichiro Kawada

Director/Board Member	01/03/2016	-
Director of Finance/CFO	01/03/2012	-
Investor Relations Contact	-	-
Corporate Officer/Principal	01/03/2009	01/03/2012

Yasushi Honma

Comptroller/Controller/Auditor

01/07/2008

Akihiro Furuta

Director/Board Member	01/07/2008	-
Chief Operating Officer	08/06/2012	01/08/2014
Chief Tech/Sci/R&D Officer	14/07/2011	08/06/2012
Human Resources Officer	08/06/2012	01/08/2014
Corporate Officer/Principal	01/08/2014	-

Akimitsu Hirai

Director/Board Member

01/03/2010

Shinichi Koizumi

Director/Board Member	14/07/2011	01/08/2014
Chief Tech/Sci/R&D Officer	14/07/2011	29/11/2012
Corporate Officer/Principal	-	-

Susumu Tsuchiya

Chief Administrative Officer	01/03/2010	01/08/2014
Director/Board Member	01/03/2010	-
Human Resources Officer	01/03/2010	08/06/2012

Atsushi Nagahisa

Director/Board Member	14/07/2011	-
President	14/07/2011	29/11/2012

Sanshiro Horii

Comptroller/Controller/Auditor	14/07/2011	-
Director of Finance/CFO	14/07/2011	08/06/2012
Investor Relations Contact	14/07/2011	-

Kazuhiro Ikeda

General Counsel	08/06/2012	-
Corporate Officer/Principal	14/07/2011	08/06/2012

Michael Warner

Corporate Officer/Principal

Tomoko Nii

Corporate Officer/Principal

14/07/2011

Age distribution of managers

Parity Men Women

Male	12
Female	0

Of which Executive Committee

Male	3
Female	0

Of which Directors

Male	8
Female	0

RaQualia Pharma Inc. is a Japan-based company engaged in the research and development of pharmaceutical products. The Company is mainly engaged in the discovery and research, the preclinical trials and part of clinical trials of drugs, as well as the licensing of developed compounds to pharmaceutical companies. The Company is focused on pain diseases area and intestinal disease area. Its products include EP4 antagonist, cyclooxygenase-2 (COX-2) inhibitory, 5-HT4 portion partial agonist, among others.

Employees

Sector

Pharmaceuticals

More about the company